A Single and Repeated Dose Escalation of RBD1016 in Subjects with Chronic Hepatitis B Virus (HBV) Infection
Clinical trial NCT05017116 · COMPLETED
Trial details
- NCT number
- NCT05017116
- Sponsor
- Suzhou Ribo Life Science Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-09
- Primary completion
- 2023-10-25
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.